DPP-IV inhibitor (BF = 0.6667): high potential inhibitory effect on DPP-IV, indicating potential benefits in metabolic regulation and diabetes control; ACE inhibitor (BF = 0.6000): high potential for cardiovascular protection through ACE inhibition. The gene discussed is ACE; the disease is diabetes mellitus.